Novartis (NVS) PT Raised to $170 at Morgan Stanley
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $161.25 +6.04%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Morgan Stanley analyst Thibault Boutherin raised the price target on Novartis (NYSE: NVS) to $170.00 (from $143.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- Ser Educacional SA (SEER3:BZ) PT Raised to R$23 at JPMorgan
- Ecopetrol SA (ECOPETL:CB) (EC) PT Raised to $2,970 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
